Variant · Snv
HRAS NM_005343.4(HRAS):c.38G>T (p.Gly13Val)
CI-VAR-00025932Explore in graph →p.Gly13ValNM_005343.4:c.38G>TClinVar 180848 rs104894226
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 180848 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Costello syndrome; Lip and oral cavity carcinoma; KA-like vemurafenib-induced squamous lesions; Large congenital melanocytic nevus; Linear nevus sebaceous syndrome; Neoplasm; Rhabdomyosarcoma | germline/somatic | 13 | Oct 31, 2025 | clinvar |